Covered recipient · General Payments record
VAN W ADAMSON
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$3,402.12
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,130.37 | 4 |
| Food and Beverage | $749.12 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,554.76 | 13 |
| Acerta Pharma LLC | $121.70 | 1 |
| Esperion Therapeutics, Inc. | $120.56 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.97 | 2 |
| Amgen Inc. | $27.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.50 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115409423 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104218993 | CMS |
| Esperion Therapeutics, Inc. | $120.56 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129425190 | CMS |
| Medtronic, Inc. | $660.27 | 01/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119308294 | CMS |
| Medtronic, Inc. | $58.30 | 01/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119308296 | CMS |
| Medtronic, Inc. | $358.00 | 01/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119308316 | CMS |
| Medtronic, Inc. | $53.80 | 01/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119308318 | CMS |
| Medtronic, Inc. | $39.99 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308298 | CMS |
| Medtronic, Inc. | $45.75 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308300 | CMS |
| Medtronic, Inc. | $24.89 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308302 | CMS |
| Medtronic, Inc. | $63.25 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308304 | CMS |
| Medtronic, Inc. | $12.60 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308306 | CMS |
| Medtronic, Inc. | $139.73 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308308 | CMS |
| Medtronic, Inc. | $48.59 | 01/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308310 | CMS |
| Medtronic, Inc. | $19.29 | 01/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308312 | CMS |
| Medtronic, Inc. | $30.30 | 01/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308314 | CMS |
| Novartis Pharmaceuticals Corporation | $32.36 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086762691 | CMS |
| Novartis Pharmaceuticals Corporation | $22.61 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086762703 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.